Clinical trial
Effectiveness and Safety of Endovascular Treatment vs. Best Medical Treatment in Patients With Vertebrobasilar Artery Occlusion Presenting Beyond 24 Hours of Last Known Well:a Prospective, Multicenter Registry Study
NCT06510634 is registered in ClinicalTrials.gov with Tianjin Huanhu Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Endovascular Treatment vs. Best Medical Treatment in Patients With Vertebrobasilar Artery Occlusion Presenting Beyond 24 Hours of Last Known Well:a Prospective, Multicenter Registry Study
- Lead sponsor
- Tianjin Huanhu Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2019
- Completion date
- March 31, 2028
- Enrollment
- 236 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stroke, ischemic